-
Abdul El-Sayed declares victory in Michigan Senate contest
-
Kuwait marks key events and anniversaries from national history
-
Democrats Seize Congress in Midterm Sweep, Ending Trump Era Control
-
Democrats capture US Congress in sweeping midterm victory
-
Trump congratulates Democrats and signals willingness to cooperate
-
Manchester United rallies past Roma as PSG dominates in Champions League
-
Enel to Install Solar Panels at Niterói Waste Management Facility
-
Qatar prime minister advances mediation through diplomatic calls
-
Qatar sees tentative opening for renewed regional diplomacy
-
Greenland parliament approves security agreement with United States
-
Qatar Tourism joins Pacific Asia Travel Association at London travel market
-
Qatar envoy meets incoming UN General Assembly president
-
Abdul El-Sayed Wins Michigan Senate Seat in Historic Election
-
Trump Signals Willingness to Work With Democrats After Midterm Defeat
-
Qatar media bodies discuss support for humanitarian initiatives
-
Ispire Technology Inc. Schedules Fiscal First Quarter 2027 Earnings Conference Call
-
Dolphin to Host Third Quarter 2026 Earnings Conference Call on Nov 10, 2026
-
Wipeboard Family Launches Free AI Chore Planner That Builds Age-Appropriate Chore Plans in Seconds
-
Medical Care Technologies Inc. (OTCID:MDCE) Moves $250,000 Software Agreement Into Active Development
-
InstaLILY Research Finds One in Six Leaders Across the Supply Chain Faced an AI Incident Involving Supplier or Customer Data
-
PAVS Subsidiary 2Lab3 Launches AniMano+, an AI-Native Digital Entertainment Streaming Platform, on the Apple App Store
-
LightPath Technologies to Host First Quarter Fiscal 2027 Earnings Call on November 10 at 5:00 p.m. Eastern Time
-
Ondas Secures Multi-Million-Dollar Counter-UAS Contracts in Europe and Asia, Accelerating Global Expansion in Aerial Defense
-
QualSights Secures $5 Million Financing and Appoints Prasanna Pitale CEO to Accelerate Company Growth
-
Sidney Resources Secures Federal Approval for Historic Gold and Silver Ore Mobilization
-
Adcore to Publish Third Quarter 2026 Results on November 10, 2026
-
IRS Postpones Texas Tax Deadlines to February 1, 2027 After July Storms - Clear Start Tax Explains What a Disaster Postponement Does Not Pause
-
Dateline and US Government Seek Ninth Circuit Stay
-
Wedgewood Weddings Expands to Maryland With Grey Rock Mansion
-
Worksport Signs Term Sheet to Acquire U.S. Manufactured Truck Bed Accessory Business & Accompanying IP Portfolio
-
Jumia to Announce Third Quarter 2026 Results on November 18, 2026
-
First Canadian Graphite Inc. Closes Flow-Through Financing
-
Apollo Wellness Centers Releases Primer Video
-
RSI Welcomes The Orange County Comptroller's Office as Its Newest Government Premier Partner
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 04
-
Facet Welcomes Three-Time PGA Tour Winner Ben Griffin as Newest Brand Partner
-
SMX Announces Effective Date of Reverse Stock Split
-
ELEKTROS Advances Review of Potential U.S. Lithium Opportunity as Critical Minerals Gain Strategic Momentum
-
Midterm 2026 Healthcare Ballot Results and Impacts Across 13 States: Black Book Research Follow-Up
-
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
-
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17
-
ELEKTROS Highlights Northern New York Lithium Potential Amid Growing Focus on Domestic Battery Supply
-
ELEKTROS Brings Lithium Opportunity and Patented EV Charging Technology Into Focus for Investors
-
Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
-
GoWish Hits 20 Million Registered Users Worldwide and Surpasses 100 Million Wishes Created in the US This Year
-
Cosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve Months
-
Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance
-
Chervon Announces Partnership with Wrestlers in Business Network to Expand Its AMP Talent Program
-
LiveOne (NASDAQ:LVO) Extinguishes $8.5 Million in JGB Debt, Reducing Balance from $17.5 Million to $9 Million
-
Chilean Cobalt Corp. Signs Definitive Option Agreement to Consolidate Substantially All of the Past-Producing La Cobaltera Project Area
'Unnoticed, catastrophic': Rising opioid fears in Eastern Europe
Eastern Europe, once seen as immune to the opioid crisis wreaking havoc across North America, has been ramping up its fight against the rise of the dangerous, synthetic drugs.
There have been dozens of deaths and many more arrests in Poland this year linked to synthetic drugs, including mephedrone -- an alternative to cocaine -- as well as fentanyl and nitazenes.
Poland's Central Investigation Bureau of Police has dismantled 33 illegal synthetic drug "factories" this year, according to its spokesman Krzysztof Wrzesniowski.
Two of them were exclusively producing mephedrone, used to replace cocaine at a cheaper cost.
Aside from causing problems in Poland, media reports found that such laboratories were also found to be exporting drugs throughout the European Union, including to the neighbouring Czech Republic and Slovakia.
"It is a constant race between criminals who produce these substances... and laboratories and the sanitary inspection," Poland's Chief Sanitary Inspector Pawel Grzesiowski said.
"They are constantly looking for new substances, new varieties."
- 'Crooked drug business' -
Zuromin, a town of about 9,000 people two hours north of Warsaw, has been named the region's unofficial fentanyl capital.
For some, it is reminiscent of small towns in the United States which were the first to fall victim to the country's opioid epidemic.
In June, local police seized a total of 300 patches of the drug, capable of intoxicating 4,800 people, and arrested four people suspected of involvement in the illegal fentanyl trade.
But for the town's residents, this is not a new problem.
"From the beginning, the problem seemed to me to be marginalised, unnoticed, catastrophic," Adam Ejnik, a teacher and journalist from Zuromin, told AFP.
As early as 2015, Zuromin's inhabitants appealed for help in an open letter published in the local newspaper.
"No city in Poland has such statistics," the letter read.
In response to growing concern, Poland's health ministry introduced a system for monitoring opioid prescriptions, building upon an existing policy to limit the amount of prescriptions by individual doctors.
Widespread fears prompted Prime Minister Donald Tusk to call a meeting with the attorney general, health minister and police chiefs.
"No one who is involved in this crooked drug business in Poland will remain safe," Tusk said in a statement on X.
- Replacing heroin -
Until recently, fentanyl constituted "a rather small problem for Europe", with one notable exception, Thomas Pietschmann, a senior research official at the United Nations Office on Drugs and Crime, told AFP.
"For a long time... Estonia was really the outlier in this story."
Issues with fentanyl in the Baltic country first began in 2001, owing to Taliban bans on heroin.
"In Estonia, instead of the heroin, people switched to fentanyl," Pietschmann said, adding that the drugs initially came from neighbouring Russia.
Since then, the use of synthetic opioids, including fentanyl, "is on the rise" in fellow Baltic state Lithuania, a spokesperson for the Lithuanian health ministry, Julijanas Galisanskis, told AFP.
Pietschmann, one of the main authors of the World Drug Report 2024, warned that the 95 percent reduction in Afghan opium production would "be felt on the market" and people will likely "switch to other opiates".
"The most problematic ones will be the fentanyls or the nitazenes."
Nitazenes -- "synthetic opioids which can be even more potent than fentanyl," according to the UN -- have also emerged in high-income countries, including Latvia, Estonia and France.
Nitazenes are "one of the main problems" on the drug market in Estonia, said Mikk Oja, a senior specialist at the country's National Institute for Health Development.
"The heroin shortage could bring a spike in synthetic opioids in other countries too, and with it likely a serious spike in overdose deaths," Oja added.
Experts warn that the potency of fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine, poses additional risks.
"The advantage of fentanyl as a highly efficient drug for cartels is obvious –- you don't have to transport dozens of tons, you can only transport dozens of kilos," the Czech government's director for anti-drug policy, Jindrich Voboril, told AFP.
"We have to be careful, because the problem may emerge quite fast."
E.Flores--AT